Total Payments
$4.0M
2024 Payments
$514,610
Companies
73
Transactions
2,423
Medicare Patients
2,076
Medicare Billing
$296,238
Payment Breakdown by Category
Consulting$2.2M (55.0%)
Other$1.4M (34.5%)
Royalty/License$185,500 (4.6%)
Travel$159,242 (4.0%)
Food & Beverage$64,237 (1.6%)
Education$6,576 (0.2%)
Research$3,043 (0.1%)
Gifts$59.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.2M | 683 | 55.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $875,723 | 205 | 21.8% |
| Honoraria | $193,766 | 66 | 4.8% |
| Royalty or License | $185,500 | 4 | 4.6% |
| Travel and Lodging | $159,242 | 481 | 4.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $151,368 | 72 | 3.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $103,900 | 35 | 2.6% |
| Food and Beverage | $64,237 | 846 | 1.6% |
| Acquisitions | $55,613 | 1 | 1.4% |
| Education | $6,576 | 6 | 0.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $5,175 | 2 | 0.1% |
| Unspecified | $3,043 | 19 | 0.1% |
| Gift | $59.99 | 2 | 0.0% |
| Entertainment | $50.00 | 1 | 0.0% |
Payments by Type
General
$4.0M
2,404 transactions
Research
$3,043
1 transactions
Ownership
$0
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $501,861 | 309 | $0 (2024) |
| Oasis Medical, Inc. | $334,144 | 33 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $260,918 | 181 | $0 (2021) |
| Shire North American Group Inc | $234,133 | 302 | $0 (2019) |
| Alcon Research LLC | $195,061 | 10 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $193,247 | 202 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $146,356 | 123 | $0 (2024) |
| Atlas Ocular, Inc | $127,833 | 4 | $0 (2024) |
| OCULUS, Inc. | $123,500 | 28 | $0 (2024) |
| Allergan, Inc. | $120,881 | 102 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514,610 | 370 | Mallinckrodt Hospital Products Inc. ($124,266) |
| 2023 | $456,727 | 263 | Mallinckrodt Hospital Products Inc. ($110,110) |
| 2022 | $448,033 | 275 | Mallinckrodt Hospital Products Inc. ($97,732) |
| 2021 | $528,810 | 265 | Mallinckrodt Hospital Products Inc. ($101,195) |
| 2020 | $463,533 | 210 | Mallinckrodt Hospital Products Inc. ($68,557) |
| 2019 | $518,497 | 364 | Bausch & Lomb, a division of Bausch Health US, LLC ($69,050) |
| 2018 | $743,107 | 402 | Alcon Research Ltd ($156,101) |
| 2017 | $337,421 | 274 | Allergan Inc. ($57,944) |
All Payment Transactions
2,423 individual payment records from CMS Open Payments — Page 1 of 97
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Atlas Ocular, Inc | — | Consulting Fee | Cash or cash equivalent | $18,000.00 | General |
| 12/31/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Ophthalmology | ||||||
| 12/30/2024 | Nordic Pharma, Inc. | Lacrifill (Device) | Consulting Fee | Cash or cash equivalent | $14,355.56 | General |
| Category: Opthalmics | ||||||
| 12/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $937.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/15/2024 | Harrow Eye, LLC | VEVYE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: OPTOMETRY | ||||||
| 12/14/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $51.24 | General |
| 12/14/2024 | Bausch & Lomb Americas Inc. | — | Travel and Lodging | In-kind items and services | $45.56 | General |
| 12/14/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $37.27 | General |
| 12/14/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 12/14/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $16.85 | General |
| 12/13/2024 | Bausch & Lomb Americas Inc. | — | Travel and Lodging | In-kind items and services | $437.96 | General |
| 12/13/2024 | Bausch & Lomb Americas Inc. | — | Travel and Lodging | In-kind items and services | $318.62 | General |
| 12/13/2024 | Bausch & Lomb Americas Inc. | — | Travel and Lodging | In-kind items and services | $102.35 | General |
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 12/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,800.00 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Topcon Healthcare, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 12/09/2024 | Topcon Healthcare, Inc. | — | Travel and Lodging | Cash or cash equivalent | $1,318.59 | General |
| 12/09/2024 | Topcon Healthcare, Inc. | — | Travel and Lodging | Cash or cash equivalent | $238.86 | General |
| 12/09/2024 | Topcon Healthcare, Inc. | — | Travel and Lodging | Cash or cash equivalent | $80.41 | General |
| 12/09/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Topcon Healthcare, Inc. | — | Travel and Lodging | Cash or cash equivalent | $24.12 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Pooled by Severity | Oyster Point Pharma, Inc. | $3,043 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 392 | 889 | $121,716 | $79,689 |
| 2022 | 6 | 361 | 881 | $113,891 | $76,809 |
| 2021 | 8 | 688 | 1,544 | $131,159 | $77,423 |
| 2020 | 8 | 635 | 1,319 | $112,718 | $62,318 |
Total Patients
2,076
Total Services
4,633
Medicare Billing
$296,238
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2023 | 21 | 42 | $57,950 | $38,405 | 66.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 289 | $38,286 | $25,292 | 66.1% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 122 | 410 | $11,304 | $9,032 | 79.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 102 | $10,372 | $5,040 | 48.6% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 32 | 32 | $2,880 | $1,689 | 58.6% |
| 92285 | Photography of content of eyes | Office | 2023 | 12 | 14 | $924.00 | $232.26 | 25.1% |
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2022 | 24 | 45 | $63,000 | $43,509 | 69.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 300 | $29,235 | $17,452 | 59.7% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 129 | 446 | $11,956 | $9,907 | 82.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 35 | $4,666 | $3,235 | 69.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 27 | 27 | $2,430 | $1,358 | 55.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 25 | 28 | $2,604 | $1,348 | 51.8% |
| 65778 | Insertion of amniotic membrane to eye surface | Office | 2021 | 17 | 24 | $35,400 | $24,963 | 70.5% |
| 83861 | Microfluid analysis of tears | Office | 2021 | 236 | 876 | $33,246 | $19,650 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 156 | 295 | $29,809 | $18,255 | 61.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 102 | 130 | $13,358 | $6,862 | 51.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 58 | $8,587 | $4,307 | 50.2% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 32 | 32 | $2,864 | $1,666 | 58.2% |
| 92285 | Photography of content of eyes | Office | 2021 | 77 | 95 | $6,263 | $1,350 | 21.6% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2021 | 17 | 34 | $1,632 | $370.58 | 22.7% |
| 65778 | Insertion of amniotic membrane to eye surface | Office | 2020 | 17 | 20 | $34,450 | $20,349 | 59.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 222 | $25,780 | $15,618 | 60.6% |
| 83861 | Microfluid analysis of tears | Office | 2020 | 206 | 667 | $24,453 | $14,220 | 58.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 65 | 72 | $7,320 | $4,653 | 63.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 63 | 73 | $6,329 | $3,614 | 57.1% |
About Dr. Paul Karpecki, OD
Dr. Paul Karpecki, OD is a Optometrist healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619910569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Karpecki, OD has received a total of $4.0M in payments from pharmaceutical and medical device companies, with $514,610 received in 2024. These payments were reported across 2,423 transactions from 73 companies. The most common payment nature is "Consulting Fee" ($2.2M).
As a Medicare-enrolled provider, Karpecki has provided services to 2,076 Medicare beneficiaries, totaling 4,633 services with total Medicare billing of $296,238. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist, Corneal and Contact Management
- Location Lexington, KY
- Active Since 06/14/2006
- Last Updated 11/28/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1619910569
Products in Payments
- ACTHAR (Biological) $528,542
- XIIDRA (Drug) $256,594
- OASIS TEARS (Drug) $229,144
- Prokera (Device) $112,285
- ULTRA (Device) $95,554
- AdaptDx (Device) $91,039
- Cequa (Drug) $85,655
- NGENUITY (Device) $79,679
- BIOTRUE (Device) $76,304
- OXERVATE (Drug) $75,081
- MIEBO (Drug) $74,542
- OCULUS Keratograph 5M (Device) $63,000
- Hydrus (Device) $61,728
- Keratograph (Device) $56,000
- RXSIGHT CONTACT LENS (Device) $55,662
- HYDRUS Microstent (Device) $55,635
- VEVYE (Drug) $53,433
- CEQUA (Drug) $50,477
- LOTEMAX SM (Drug) $48,026
- Tecnis 1-piece IOL (Device) $42,050
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lexington
Bilal Ahmad, O.d, O.D
Optometrist — Payments: $131,768
Optometrist $131,768
Christopher Kuc, Od, OD
Optometrist — Payments: $14,881
Optometrist $14,881
Dr. Joe Mcmillin, Od, OD
Optometrist — Payments: $14,785
Optometrist $14,785
Dr. Karen Mcmillin, O.d, O.D
Optometrist — Payments: $12,916
Optometrist $12,916
Mrs. Kelly Trussell, O.d, O.D
Optometrist — Payments: $12,402
Optometrist $12,402
Howell Findley, Od, OD
Optometrist — Payments: $7,459
Optometrist $7,459